More Exercise, Less Disease
Many past studies have shown that physical activity provides health benefits, but exactly how much physical activity provides the most benefit?
Cancer Screening: It Could Be Hard to Get the Facts
Most people would agree that cancer screening is a good thing. After all, you're either preventing cancer or catching it early. Unfortunately, the majority of cancer screening guidelines may be lacking in important patient information.
Device to Reduce Chemo Hair Loss Cleared for Marketing
Today, the U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.
Metastatic Cancer: How Cancer Spreads
Learning that a cancer has metastasized may be one of the scariest things you can hear from your doctor. Metastatic cancers are responsible for 90 percent of all cancer-related deaths. Here is an introduction to the fundamentals of how cancer develops and spreads.
Standard Medication for HER-2 Breast Cancer Remained Top Rx
The approval of a new medication represents new options for patients. But the new option isn't always the best option. When it comes to treating HER-2 positive breast cancer, the standard medication still appears to beat the newer option.
Call for Genetic Screening to Become New Norm
Gene mutations associated with higher rates of breast and ovarian cancer may pose a serious risk to Ashkenazi Jewish (AJ) women, even those without a family history of cancer. This prompted a call for more genetic cancer screening.
Understanding Breast Cancer Genes
Between 5 and 10 percent of breast cancer cases have a genetic basis. While it might be tempting to know whether you have a mutated breast cancer gene, genetic testing is only recommended for people with certain risk factors.
Benefits of Regular Physical Activity
There are many health benefits to being a physically active person. Here’s a list from what you might gain from developing an exercise routine.
Men With Breast Cancer Treated Differently
While breast cancer is one of the most common cancers in women, it’s one of the least common in men. Both sexes have similar survival rates. However, researchers have discovered major differences in treatment approaches.
FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment
The US Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting).